NCT00273299View on ClinicalTrials.gov

Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

607

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Hypertension
Interventions
DRUG

valsartan plus hydrochlorothiazide

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00273299 - Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension | Biotech Hunter | Biotech Hunter